Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-17177, Stockholm, Sweden.
Genome Institute of Singapore, 138672, Singapore, Singapore.
Breast Cancer Res. 2018 Jan 23;20(1):6. doi: 10.1186/s13058-017-0930-6.
Preeclampsia is frequently linked to reduced breast cancer risk. However, little is known regarding the underlying genetic association and the association between preeclampsia and mammographic density.
This study estimates the incidence rate ratios (IRRs) of breast cancer in patients with preeclampsia, when compared to women without preeclampsia, using Poisson regression models in two cohorts of pregnant women: a Swedish nationwide cohort (n = 1,337,934, 1973-2011) and the Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA, n = 55,044, 1958-2015). To identify the genetic association between preeclampsia and breast cancer, we used logistic regression models to calculate the odds ratios (ORs) of preeclampsia in sisters of breast cancer patients, and in women with different percentiles of breast cancer polygenic risk scores (PRS). Linear regression models were used to estimate the mammographic density by preeclampsia status in the KARMA cohort.
A decreased risk of breast cancer was observed among patients with preeclampsia in both the nationwide (IRR = 0.90, 95% CI = 0.85; 0.96) and KARMA cohorts (IRR = 0.75, 95% CI = 0.61; 0.93). Women with high breast cancer PRS and sisters of breast cancer patients had a lower risk of preeclampsia (OR = 0.89, 95% CI = 0.83; 0.96). Mammographic density was lower in women with preeclampsia compared to women without preeclampsia (-2.04%, 95% CI = -2.65; -1.43). Additionally, among sisters in the KARMA cohort (N = 3500), density was lower in sisters of patients with preeclampsia compared to sisters of women without preeclampsia (-2.76%, 95% CI = -4.96; -0.56).
Preeclampsia is associated with reduced risk of breast cancer and mammographic density. Inherited factors contribute to this inverse association.
子痫前期与乳腺癌风险降低有关。然而,关于潜在的遗传关联以及子痫前期与乳腺 X 线摄影密度之间的关联知之甚少。
本研究使用泊松回归模型,在两个孕妇队列中估计子痫前期患者的乳腺癌发病率比(IRR),与无子痫前期的女性相比:一个是瑞典全国队列(n=1,337,934,1973-2011 年)和 Karolinska 乳腺癌风险预测乳腺 X 线摄影项目(KARMA,n=55,044,1958-2015 年)。为了确定子痫前期与乳腺癌之间的遗传关联,我们使用逻辑回归模型计算了乳腺癌患者姐妹和不同乳腺癌多基因风险评分(PRS)百分位数的子痫前期发生的比值比(OR)。线性回归模型用于估计 KARMA 队列中按子痫前期状态划分的乳腺 X 线摄影密度。
在全国性队列(IRR=0.90,95%CI=0.85;0.96)和 KARMA 队列(IRR=0.75,95%CI=0.61;0.93)中,子痫前期患者的乳腺癌风险均降低。乳腺癌 PRS 较高的女性和乳腺癌患者的姐妹子痫前期风险较低(OR=0.89,95%CI=0.83;0.96)。与无子痫前期的女性相比,患有子痫前期的女性乳腺 X 线摄影密度较低(-2.04%,95%CI=-2.65%;-1.43%)。此外,在 KARMA 队列中的姐妹中(N=3500),与无子痫前期的女性相比,子痫前期患者的姐妹的密度较低(-2.76%,95%CI=-4.96%;-0.56%)。
子痫前期与乳腺癌风险降低和乳腺 X 线摄影密度降低有关。遗传因素促成了这种反比关系。